Orvida Pharma Ltd.
- Address
- Science Park, 3 Pinkhas Sapir
Sponsor Overview
Specializations
Dermatologic and Genetic Rare Disease Research
Kamari Pharma Ltd. is involved in clinical research centered on Olmsted syndrome, a rare genodermatosis marked by severe skin involvement and complex keratinization disorders. Its research activity reflects a focus on conditions with limited therapeutic options and high unmet medical need.
- Olmsted syndrome
- Rare dermatologic disorders
- Inherited skin disease
The sponsor’s clinical interest lies in advancing treatment options for patients affected by uncommon skin disease with a genetic basis.
Translational and Early-Stage Therapeutic Development
The company’s research portfolio includes early clinical evaluation in both healthy volunteers and patients, indicating a strong interest in translating novel therapeutic concepts into human studies for rare dermatology indications.
- Early human clinical research
- Rare disease therapeutics
- Patient-focused intervention development
This area highlights work aimed at understanding treatment relevance in a rare-disease setting where clinical evidence remains limited.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Phase 1a/1b Evaluation of KM-023 in Healthy Volunteers and Patients with Olmsted Syndrome | France Germany | Recruiting |
Data & Insights
This sponsor works with 0 molecules, of which 0 are not being studied by other sponsors.
This sponsor has worked with 3 sites across their trial portfolio.
Therapeutic Focus
- 1.Skin and Connective Tissue Diseases1 trial247 other sponsors
Partnered Research Centres
3 centres- Address
- 7 Rue Jean Louis Bertrand, 35000 Rennes
- Address
- 149 Rue De Sevres, 75015 Paris
- Address
- Ulmenweg 18, Innenstadt, 91054 Erlangen
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Orvida Pharma Ltd..
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.


